Moderate Evidence

Promising research with growing clinical support from multiple studies

Alternatives for Alzheimer's Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative condition marked by memory loss, impaired thinking, and changes in behavior. Biologically, it involves abnormal accumulation of amyloid-beta plaques and tau tangles, synaptic dysfunction, and neuroinflammation. While Western medicine has clarified the biology and improved diagnostic accuracy with cerebrospinal fluid and blood biomarkers, amyloid/tau PET imaging, and structured cognitive testing, many families still face modest symptom relief, treatment side effects, and care burdens. These realities drive interest in “alternatives” — a broad umbrella that includes lifestyle strategies, nutraceuticals, neuromodulation, and traditional systems like Traditional Chinese Medicine (TCM) and Ayurveda. From a Western perspective, several nonpharmacologic options have comparatively strong or moderate evidence. Regular physical activity (aerobic and resistance training) is consistently linked to better cognition and function in mild cognitive impairment (MCI) and early AD, potentially by improving cerebral blood flow, insulin sensitivity, and neurotrophic signaling. Dietary patterns such as Mediterranean and MIND diets emphasize vegetables, legumes, whole grains, fish, olive oil, and berries; observational and interventional studies suggest these patterns may slow cognitive decline and support brain health via vascular and anti-inflammatory pathways. Good sleep hygiene and treating sleep apnea can stabilize attention and memory and may reduce amyloid burden over time. Cognitive training and structured cognitive stimulation therapies can maintain daily function and selected cognitive domains. Hearing and vision correction, social engagement, and safe home environments all support quality of life. Nutraceuticals attract attention but have mixed evidence. Omega-3 fatty acids (DHA/EPA) may benefit people with low dietary intake or earlier-stage cognitive changes, though large trials in established AD generally show no,

neurological Updated March 17, 2026

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.

Western Medicine

Diagnosis

Western medicine identifies Alzheimer’s disease using clinical criteria (e.g., NIA–AA), neuropsychological testing, and, when available, biomarkers: MRI to assess atrophy and vascular changes; amyloid and tau PET imaging; cerebrospinal fluid or blood biomarkers (Aβ42/40, p‑tau181/p‑tau217, neurofilament light). Differential diagnosis considers other dementias, depression, delirium, medication effects, and metabolic causes.

Treatments

  • Lifestyle: regular aerobic and resistance exercise tailored to ability
  • Dietary patterns: Mediterranean or MIND-style eating emphasizing plants, fish, olive oil, and berries
  • Sleep optimization and treatment of sleep apnea with appropriate devices
  • Cognitive stimulation/rehabilitation and structured cognitive training
  • Hearing and vision optimization; social engagement; caregiver education; environmental modifications for safety
  • Neuromodulation: repetitive transcranial magnetic stimulation (rTMS) or transcranial direct current stimulation (tDCS) as adjuncts
  • Nutraceuticals (evidence varies): omega‑3 fatty acids (DHA/EPA), B‑vitamins targeting elevated homocysteine, curcumin, huperzine A
  • Symptomatic medications: cholinesterase inhibitors and NMDA receptor antagonist
  • Disease‑modifying monoclonal antibodies in early symptomatic disease: lecanemab; donanemab
  • Management of cardiovascular risks (hypertension, diabetes), depression, anxiety, pain, and sleep disorders

Medications

  • donepezil
  • rivastigmine
  • galantamine
  • memantine
  • lecanemab
  • donanemab
  • aducanumab

Limitations

Symptomatic drugs offer modest benefits and may cause gastrointestinal effects, bradycardia, weight loss (cholinesterase inhibitors) or dizziness and confusion (memantine). Anti‑amyloid antibodies can slow decline in early disease but require infusions, MRI monitoring, and carry risk of ARIA (brain edema/microbleeds); access and cost can be significant. Lifestyle trials vary in intensity and adherence, making real‑world implementation challenging. Nutraceuticals often lack consistent, high‑quality randomized trials in diagnosed AD and can interact with prescribed drugs. Individual responses vary due to disease stage, comorbidities, and genetics (e.g., APOE ε4).

Evidence: Strong Evidence

Sources

  • NIA–AA research framework and updates on biomarker‑based diagnosis (2023–2024)
  • American Academy of Neurology practice guidance on dementia/MCI management (2018–2020 updates)
  • The 2020 Lancet Commission on dementia prevention, intervention, and care
  • World Health Organization 2019 guidelines on risk reduction of cognitive decline and dementia
  • A 2023 Cochrane review on exercise for people with dementia reported small improvements in physical function with mixed cognitive effects
  • A 2023 Cochrane review of cognitive training/stimulation noted small to moderate benefits in selected domains
  • FDA communications (2023–2024) on lecanemab and donanemab approvals for early Alzheimer’s disease
  • A 2020 Cochrane review on omega‑3 fatty acids found little to no benefit in established dementia
  • Randomized trials/meta‑analyses (2010–2022) suggest B‑vitamins may slow brain atrophy in people with high homocysteine, with uncertain cognitive impact in AD
  • Meta‑analyses (2020–2023) indicate rTMS may modestly improve cognition short‑term as an adjunct; tDCS findings are mixed

Eastern & Traditional Medicine

Traditional Chinese Medicine (TCM)

TCM views cognitive decline through patterns such as kidney essence deficiency, spleen qi deficiency, and phlegm‑damp obstructing the orifices, contributing to poor clarity and memory. Treatment seeks to tonify essence and qi, transform phlegm, move blood, and calm the shen (mind/spirit). Proposed mechanisms overlap with modern concepts: modulation of neuroinflammation, cholinergic signaling, cerebral perfusion, and neuroplasticity.

Techniques

  • Acupuncture body points commonly used: DU20 (Baihui), EX‑HN1 (Sishencong), ST36 (Zusanli), KI3 (Taixi), PC6 (Neiguan); scalp acupuncture protocols
  • Herbal formulas individualized by pattern; examples reported in studies include Bushen Yizhi granules and formulations to tonify kidney and spleen and resolve phlegm
  • Single‑herb constituents studied: Huperzia serrata (source of huperzine A), Polygala tenuifolia (Yuan Zhi), Acorus tatarinowii (Shi Chang Pu)
  • Qigong or Tai Chi as adjunct mind‑body practices emphasizing gentle movement and breath
Licensed acupuncturists (L.Ac) TCM herbalists Integrative physicians with TCM training
Evidence: Emerging Research

Ayurveda

Ayurveda frames memory loss as primarily a Vata and Majja Dhatu (nervous system tissue) imbalance with depletion of ojas (vital essence). Rasayana (rejuvenative) therapies aim to nourish the nervous system, reduce oxidative stress, and calm the mind. Proposed mechanisms include antioxidant effects, modulation of cholinergic and GABAergic pathways, stress‑axis regulation, and improved sleep.

Techniques

  • Herbs: Brahmi (Bacopa monnieri), Ashwagandha (Withania somnifera), Shankhpushpi, Turmeric (Haridra)
  • Rasayana and diet: sattvic diet emphasizing whole foods, spices, and ghee; individualized meal timing and digestive support
  • Therapies: Abhyanga (oil massage), Shirodhara (warm oil stream on forehead), Nasya (medicated nasal oils)
  • Breathwork and meditation for stress and sleep
Ayurvedic practitioners (BAMS/AYT) Integrative and functional medicine clinicians with Ayurvedic training
Evidence: Emerging Research

Mind‑body movement and meditation (Tai Chi, Qigong, Yoga, Mindfulness)

These practices aim to harmonize body and mind, reduce stress reactivity, improve balance and cardiovascular fitness, and enhance attention — factors relevant to cognitive resilience. Mechanistically, they may improve cerebral perfusion, autonomic balance, sleep quality, and neurotrophic signaling.

Techniques

  • Tai Chi (e.g., Yang style), Baduanjin Qigong
  • Yoga asana with breathing (pranayama) and meditation
  • Mindfulness‑based stress reduction adapted for cognitive impairment
Certified Tai Chi/Qigong instructors Yoga therapists Mindfulness teachers with geriatric/neurologic experience
Evidence: Moderate Evidence

Sources

  • A 2022 systematic review and meta‑analysis of acupuncture for MCI/AD suggested adjunctive benefits versus medication alone, with low to moderate certainty due to risk of bias
  • A 2013 Cochrane review on huperzine A found short‑term cognitive improvements in small, mainly Chinese trials with methodological limitations
  • Randomized trials (2019–2022) report Tai Chi/Qigong improving global cognition in MCI; evidence in established AD is limited
  • Classical Ayurvedic texts (Charaka and Sushruta Samhitas) describe Rasayana for memory and longevity
  • Systematic reviews (2014–2021) find Bacopa improves memory in healthy adults and older adults; evidence in dementia is limited
  • A 2017 randomized trial reported ashwagandha improved immediate and general memory in MCI; replication in AD is needed
  • Meta‑analyses (2019–2023) show Tai Chi/Qigong can improve global cognition and executive function in MCI; functional outcomes also improve
  • Systematic reviews (2017–2021) suggest yoga and meditation benefit attention and mood in older adults; data in diagnosed AD are smaller but promising for caregiver‑assisted programs

Integrative Perspective

An integrative plan can combine strong Western foundations with selected Eastern therapies to support function, safety, and well‑being. Examples include: pairing a Mediterranean/MIND diet and progressive, supervised exercise with weekly acupuncture for mood/sleep, plus daily Tai Chi/Qigong to reinforce balance, social connection, and stress reduction. Cognitive stimulation can be layered onto rTMS when available, as trials suggest additive short‑term gains. When cholinesterase inhibitors are prescribed, clinicians should review any concurrent cholinergic botanicals (e.g., huperzine A, Polygala) due to potential additive effects like bradycardia, syncope, or increased gastrointestinal symptoms. Curcumin and other polyphenols may affect anticoagulants and drug‑metabolizing enzymes; careful medication reconciliation and monitoring reduce risks. Quality matters: select herbs and supplements verified by independent testing to minimize contamination (e.g., heavy metals in some traditional preparations) and variability in active constituents. For monoclonal antibody recipients, ensure MRI monitoring for ARIA is not delayed by complementary care schedules; avoid therapies that could increase bleeding risk if on antithrombotics. Shared decision‑making with neurology, primary care, and licensed traditional practitioners helps align goals (safety, function, caregiver capacity) and define monitoring (periodic cognitive assessments, adverse‑event checks, and biomarker tracking where available). Emerging research on combined approaches — such as acupuncture plus donepezil or rTMS plus cognitive training — suggests synergy but remains limited by small samples and heterogeneous methods. Clear documentation, slow introduction of new modalities, and early reporting of side effects help make integrative care safer. Consult your healthcare provider before making changes to your health regimen.

Sources

  1. NIA–AA research framework updates on AD biomarkers and diagnostic criteria (2023–2024)
  2. American Academy of Neurology guidance on MCI/dementia management (2018–2020)
  3. The 2020 Lancet Commission on dementia prevention, intervention, and care
  4. World Health Organization 2019 risk reduction guidelines for cognitive decline and dementia
  5. Cochrane Reviews (2019–2023) on exercise, cognitive training, and omega‑3 fatty acids in dementia
  6. Randomized trials/meta‑analyses (2010–2022) on B‑vitamins and homocysteine (e.g., VITACOG)
  7. FDA communications on lecanemab (2023) and donanemab (2024) approvals
  8. Meta‑analyses (2020–2023) on rTMS/tDCS adjunctive effects in AD
  9. A 2022 systematic review of acupuncture for MCI/AD (adjunctive benefits; low–moderate certainty)
  10. Cochrane review (2013) on huperzine A (methodological limitations; short‑term effects)
  11. Systematic reviews (2014–2021) on Bacopa monnieri and cognition; 2017 RCT of ashwagandha in MCI
  12. Meta‑analyses (2019–2023) on Tai Chi/Qigong for MCI/older adults

Related Content

comparisons

Natural Remedies for Alzheimer’s Disease: East vs West

Natural Remedies for Alzheimer’s Disease. Alzheimer’s disease (AD) is a progressive neurodegenerative condition characterized by memory loss, cognitive decline, and functional impairment. Western biomedicine defines AD by pathological protein changes—amyloid-β plaques and tau tangles—leading to synaptic failure and brain atrophy. Diagnosis

comparisons

Holistic Treatment for Alzheimer’s Disease: East vs West

Holistic Treatment for Alzheimer’s Disease. Alzheimer’s disease (AD) is a progressive neurodegenerative condition marked by memory loss, changes in thinking and behavior, and loss of independence. For families, the goals of care are often broader than slowing decline. Many prioritize day-to-day function, quality of life, emotional well‑being,

comparisons

ADHD and Alternative Medicine — East vs West: East vs West

ADHD and Alternative Medicine — East vs West. Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition marked by persistent patterns of inattention, hyperactivity, and/or impulsivity that interfere with functioning at school, work, or home. Comparing Western medical and Eastern traditional approaches can help fam

relationships

Alzheimer's Disease and Cardiovascular Disease

Alzheimer’s disease (AD) and cardiovascular disease (CVD) are tightly linked along a brain–heart axis. They share many modifiable risk factors—hypertension, diabetes, dyslipidemia, obesity, smoking, i

comparisons

Multiple Sclerosis — Western vs Eastern Complementary Care: East vs West

Multiple Sclerosis — Western vs Eastern Complementary Care. Multiple sclerosis (MS) is a chronic, immune‑mediated condition in which inflammation damages myelin and axons in the central nervous system, producing symptoms such as fatigue, numbness, weakness, visual changes, spasticity, pain, cognitive issues, and mobility limitations. Western biomedicine has

comparisons

Alternatives for Stroke Rehabilitation: East vs West

Alternatives for Stroke Rehabilitation. Stroke rehabilitation aims to restore movement, speech, cognition, sensation, and daily function after brain injury. Comparing Western and Eastern options matters because recovery is driven by neuroplasticity—the brain’s capacity to rewire with targeted, repetitive practice—and because people worldw

Health Disclaimer

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.